Tackling weight loss can sometimes feel like a never-ending roller coaster. The cycle of shedding and regaining weight can be disheartening. The good news is that innovation in the realm of weight loss has brought promising solutions like tirzepatide and semaglutide.
At our serene clinic nestled in Kailua, Hawaii, Dr. Stewart Lerner, MD, and our proficient team are committed to your well-being. Specializing in metabolic, regenerative, anti-aging, and functional medicine, Dr. Lerner recognizes the unique challenges tied to weight loss.
To help patients tackle excess weight, our team provides individualized weight management plans, which may include breakthrough medications like tirzepatide and semaglutide.
A deep dive into tirzepatide and semaglutide
While both tirzepatide (known commercially as Mounjaro®) and semaglutide (Ozempic®) were initially designed to regulate blood glucose for patients with Type 2 diabetes, their potential for weight management has become evident.
Semaglutide has secured its position with Food and Drug Administration approval under the brand name Wegovy® to address obesity. Tirzepatide is racing toward approval due to its impressive outcomes, often surpassing other weight-loss injections. As of this writing, it is used off-label for weight management.
The mechanisms of these medications differ slightly, with tirzepatide boasting dual-action capabilities that may elevate weight loss effectiveness.
Understanding how Tirzepatide and Semaglutide influence weight
At their core, both semaglutide and tirzepatide manage weight by moderating hunger, ensuring reduced food intake.
Falling under the glucagon-like peptide-1 (GLP-1) receptor agonists category, semaglutide imitates the GLP-1 hormone actions, which the digestive system releases after you eat. This hormone helps produce insulin and taps into the brain's appetite center, signaling satiation.
Pioneering its drug category, tirzepatide is a dual receptor agonist for both GLP-1 and glucose-dependent insulinotropic polypeptide (GIP). GIP, another digestive hormone, stimulates insulin release.
With the injections, heightened GIP levels prolong the digestion process, ensuring prolonged satiety. These medications also appear to cut down food cravings, further regulating calorie intake.
Is this the right choice for me?
We have generic semaglutide and tirzepatide (usually) in stock and can dispense it to any patient who is overweight. There are no "restrictions" or "approvals" needed off the insurance, and because of this we can offer a substantial discount from the pharmacy price. Please come in to discuss your individual needs. There are no obligations or commitments, and we will teach you how to stop or wean off the medicine if you desire. You do not have to stay on the medicine forever. We will guide you through the process. Many of our patients have lost 15 pounds in the first month and a few have lost 50 pounds in 5 months. The results can be life-changing.
For optimal results, these injections should align with a balanced diet and consistent exercise. On average, individuals might experience a 12% weight loss with semaglutide and an astounding 20% with tirzepatide over a span of 16 months.
There’s more to weight loss than willpower. Modern medicinal advances provide hope. If you're eager to explore these options further, connect with our dedicated team for a comprehensive weight management discussion.
With the help of medical intervention, the odds of lasting weight loss are finally in your favor. Get started today by contacting our office in Kailua, Hawaii, today.